World-Class PGx Reporting Services
Deliver accurate, easy-to-read, and clinician-ready results — without the cost of maintaining an expensive, in-house reporting infrastructure and development expertise.
Partner with a proven leader in precision pharmacogenetics.
Tens of thousands of clinicians, pharmacists, and labs use Genomind’s reporting suite for genetics-based medication management.
Why lab directors love Genomind.
By partnering with Genomind, a PGx-capable lab can focus on high-quality genetic testing while leveraging our expertise to stay current with CPIC and FDA evidence to manage complex, resource-intensive gene-drug interactions.
The value of a PGx report lies in a provider’s ability to quickly and easily support clinical decision-making. Genomind helps labs attract more providers because of the quality and simplicity of our reporting suite, evidenced by our 91% comprehension rate.
Build patient confidence in prescribing decisions
One of the many reasons I love Genomind is how their reporting suite makes it easy for my patients and their families to better understand my prescribing decisions. For example, they can see ‘I am an ultra rapid metabolizer; therefore, I may need a slightly higher dose.’ I also appreciate the pharmD consults. They are always informative.
Sheila Greiinke, DO
A PGx reporting suite tailored for every use case.
Unlike other PGx companies who have a single report for a limited use case, Genomind offers a reporting suite built for the real world. Labs and their supporting providers can access four unique reports, each tailored for different audiences and scenarios, as well as GenMedPro for real-time clinical decision support across the life of a patient.
Express Report
A concise summary of medications to avoid, along with suggested alternatives based on the patient’s unique gene-drug interaction profile and published PGx guidance.
Best for: Quick reference and treatment adjustments.
NeuroPsych Report
A comprehensive report with five sections analyzing 26 genes, offering insights into 130+ neuropsychiatric medications.
Best for: Detailed psychiatric treatment planning.
Patient Report
Designed for patients–offering an easy-to-understand summary of genetic insights and medication recommendations to discuss with their provider.
Best for: Educating patients about their genetic results.
Diagnosis Report
Visual representations of genetic results organized by clinical diagnosis, designed for fast interpretation when time is limited.
Best for: Fast, diagnosis-specific genetic insights.
Real-Time Medication Management
Genomind’s reporting suite also includes GenMedPro, the leading genetics-based medication management platform that can be utilized across the life of a patient.
- Quickly evaluate prescribing options at any time, for current and future medications
- Includes over 1,200 drugs representing >99% of the most commonly prescribed medications
- Assesses drug-drug, gene-drug, and age-drug interactions to enable providers to adjust prescriptions based on critical genetic insights
Why thousands choose Genomind every year.
As the gold standard for PGx reporting services, Genomind offers an unmatched level of reporting sophistication while providing quick turnaround times and white glove client support.
PGx Expertise
Our team — including PharmDs, PhDs, and other PGx experts — delivers clinically actionable insights backed by the latest evidence. 95% of clinicians report higher confidence in decisions using our reports.
Robust Reporting
Four unique reports offer varying levels of detail, with comprehensive gene-drug, drug-drug, and gene-drug-drug interaction analysis — with dynamic alternatives and polypharmacy guidance when using GenMedPro.
Global Scalability
Nearly 20,000 providers from over 30 different countries have used Genomind’s PGx reports. Labs can expand internationally without building local reporting infrastructure — we handle compliance, updates, and multilingual potential.
Reduced Costs
Building and maintaining a PGx reporting infrastructure can be quite costly, especially as the science of PGx continues to evolve. Save time and money by eliminating unnecessary overhead.
Proven Record
Over its ten years as a leader in PGx testing, Genomind has worked with health systems, pharmacies, domestic and international labs, government agencies, and more to elevate the utility of pharmacogenetics.
PharmD Consults
Genomind offers built-in access to genetic counselors, pharmacists, and other PGx specialists for your clients’ clinicians. These optional consultations drive utilization and satisfaction.
Let's connect.
To inquire about utilizing Genomind’s reporting suite to power your PGx lab, fill out the form.
"*" indicates required fields